Associated Papers
Genes linked to hearing and vestibular phenotypes in humans and mice: an interspecies systematic review.
Ayoub C et al.
Human Genomics, 2025
41430327 (PubMed )
Supplement: 40246_2025_891_MOESM1_ESM.xlsx › Supplementary_Table_S2.
Sensorineural hearing loss in anti-interleukin-1 treated CAPS patients: risk factors and real-life barriers-an observational study.
Satirer Ö et al.
Rheumatology (oxford, England), 2025
Genetic removal of Nlrp3 protects against age-related and R345W Efemp1-induced basal laminar deposit formation.
Ortega AJ et al.
Cell Death & Disease, 2025
Discovery of potent and selective inhibitors of human NLRP3 with a novel mechanism of action.
Wilhelmsen K et al.
The Journal of Experimental Medicine, 2025
Dysregulation of inflammasomes in autoinflammatory diseases.
Hou C et al.
Joint Bone Spine, 2025
Novel Insights into the Clinical Features, Genetic Spectrum and Clonal Evolution of Patients Carrying NLRP3 Mosaicism.
Bonet N et al.
Journal of Clinical Immunology, 2025
41026232 (PubMed )
Supplement: 10875_2025_1922_MOESM1_ESM.docx
4-octyl itaconate reduces human NLRP3 inflammasome constitutive activation with the cryopyrin-associated periodic syndrome p.R262W, p.D305N and p.T350M variants.
Molina-Lopez C et al.
Cellular and Molecular Life Sciences : Cmls, 2025
Refining treat-to-target strategies in cryopyrin-associated periodic syndromes: the role of inflammatory markers.
Satirer Ö et al.
Rheumatology (oxford, England), 2025
Mechanisms of NLRP3 activation and inhibition elucidated by functional analysis of disease-associated variants.
Feng S et al.
Nature Immunology, 2025
39930093 (PubMed )
Supplement: 41590_2025_2088_MOESM3_ESM.xlsx › Table_1
The role of gene mutations and immune responses in sensorineural hearing loss.
Zhang X et al.
International Immunopharmacology, 2024
Insights into the multifaceted role of interleukin-37 on human immune cell regulation.
Teufel LU et al.
Clinical Immunology (orlando, Fla.), 2024
Genetic removal of Nlrp3 protects against sporadic and R345W Efemp1-induced basal laminar deposit formation.
Ortega AJ et al.
Biorxiv : the Preprint Server for Biology, 2024
Novel chemotype NLRP3 inhibitors that target the CRID3-binding pocket with high potency.
Vande Walle L et al.
Life Science Alliance, 2024
Functional diversity of NLRP3 gain-of-function mutants associated with CAPS autoinflammation.
Cosson C et al.
The Journal of Experimental Medicine, 2024
1–50 of 192 papers
Select a paper to view details